Wenyong Tong

Principal Scientist MSD

Seminars

Tuesday 24th February 2026
Contrasting Engineered Cell Lines vs. Cancer Cell Lines for Conventional ADC Cell-Based Potency Assay Development
2:30 pm
  • Testing ADC potency through cytotoxicity assays, evaluating the tumour-killing activity of the payload following antibody internalisation
  • Ensuring assay robustness and specificity through the selection of a target antigen-expressing cell line
Wenyong Tong Speaker Photo - 16th World ADC London Summit